See what members are saying about lung cancer treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · March 2, 2026
Overview
Alecensa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an…
Overview
Keytruda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic small cell lung cancer and various non-small cell lung cancers. Keytruda is also referred to by its…
Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer. Opdivo is often prescribed with ipilimumab (Yervoy). Opdivo is also known by…
Overview
Tagrisso is approved by the U.S. Food and Drug Administration (FDA) for several indications related to non-small cell lung cancer (NSCLC). It is used as an adjuvant therapy (additional treatment following…
Overview
Tecentriq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with small cell or non-small cell lung cancer by itself or as an adjuvant therapy (in combination with…
Become a member to get even more